Local pharmaceutical manufacturer Adcock Ingram says its push into non-regulated products where it has better pricing power is paying off, but it is looking for growth across all its business divisions even as it grapples with pandemic-induced shifts in consumer spending.        

The group, in which Bidvest has a controlling stake, has been bulking up its presence in areas such as shoe-care products, a move that has helped the revenue contribution from products that are not price regulated rise from about a third to just under half over the past two years...

BL Premium

This article is reserved for our subscribers.

A subscription helps you enjoy the best of our business content every day along with benefits such as articles from our international business news partners; ProfileData financial data; and digital access to the Sunday Times and Sunday Times Daily.

Already subscribed? Simply sign in below.

Questions or problems? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now